Prevalence case-control study of epilepsy in three Burkina Faso villages

Acta Neurologica Scandinavica

Volumn 126, Issue 4, 2012, Pages 270-278

  Nitiema P ^a   Carabin, H ^a   Hounton, S ^b   Praet, N ^c   Cowan, L D ^a   Ganaba, R ^d   Kompaore C ^e   Tarnagda, Z ^f   Dorny, P ^c   Millogo, A ^g  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNFPA   (United States)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d African Agency for Health Education   (Burkina Faso)

^e District Sanitaire de Manga ^*  (Burkina Faso)

^f Centre National de la Recherche Scientifique et Technologique   (Burkina Faso)

^g Department of Internal Medecine   (Burkina Faso)

Author keywords

Cross sectional study; Cysticercosis; Epidemiology; Epilepsy; Sub Saharan Africa

Indexed keywords

PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGRICULTURAL WORKER; ARTICLE; BLOOD SAMPLING; BURKINA FASO; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOOD INTAKE; GRAND MAL SEIZURE; HUMAN; INTERVIEW; MALE; NEUROCYSTICERCOSIS; OCCUPATION; PIG FARMING; PORK; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCREENING; SEROPREVALENCE; SIMPLE PARTIAL SEIZURE; TAENIA SOLIUM;

ADOLESCENT; ADULT; AGE FACTORS; ANTIGENS; BURKINA FASO; CHILD; CROSS-SECTIONAL STUDIES; CYSTICERCOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84865804014     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01639.x     Document Type: Article

References (39)

1. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010;5:883-90.
2. Pal DK, Carpio A, Sander J. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000;68:137-43.
3. Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010;88:260-6.
4. Millogo A, Ratsimbazafy V, Nubukpo P, Barro S, Zongo I, Preux PM. Epilepsy and traditional medicine in Bobo-Dioulasso (Burkina Faso). Acta Neurol Scand 2004;109:250-4.
5. Nsengiyumva G, Druet-Cabanac M, Nzisabira L, Preux PM, Vergnenegre A. Economic evaluation of epilepsy in Kiremba (Burundi):a case-control study. Epilepsia 2004;45:673-7.
6. Leonardi M, Ustun T. The Global Burden of Epilepsy. Epilepsia 2002;43:21-5.
7. Jilek-Aall L, Jilek M, Kaaya J. Psychosocial study of epilepsy in Africa. Soc Sci Med 1997;45:783-95.
8. Baker GA. The psychosocial burden of epilepsy. Epilepsia 2002;43:26-30.
9. Preux PM, Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005;4:21-31.
10. Del Brutto OH, Santibáñez R, Idrovo L. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 2005;46:583-7.
11. Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 2002;58:1256-61.
12. Foyaca-Sibat H, Cowan LD, Carabin H, et al. Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa. PLoS Negl Trop Dis 2009;3:e562.
13. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E. Epilepsy and neurocysticercosis in rural Tanzania: an imaging study. Epilepsia 2009;50:987-93.
14. Degeorgio CM, Medina MT, Duron R. Neurocysticercosis. Epilepsy Curr 2004;4:107-11.
15. White CA, Garcia HH. Recent developments in the epidemiology, diagnosis, treatment, and prevention of neurocysticercosis. Curr Infect Dis Rep 1999;1:434-40.
16. Carabin H, Ndimubanzi PC, Budke C, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 2011;5:e1152.
17. Preux PM, Druet-Cabanac M, Debrock C, Tapie P, Dumas M. Comité de recherche sur l'épilepsiede l'Institut d'épidémiologie neurologique et de neurologie tropicale de Limoges. [Questionnaire for the investigation of epilepsy in tropical countries]. Afr J Neurol Sci 2003;22. Available at: http://www.ajns.paans.org/article.php3?id_article=96
18. Senanayake N, Roman GC. Epidemiology of epilepsy in developing countries. Bull World Health Organ 1993;71:247-58.
19. Engel J. Report of the ILAE Classification Core Group. Epilepsia 2006;47:1558-68.
20. Brandt JRA, Geerts S, De Deken R, et al. A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. Int J Parasitol 1992;22:471-7.
21. Van Kerckhoven I, Van Steenkiste W, Claes M, Geerts S. Improved detection of circulating antigen in cattle infected with Taenia saginata metacestodes. Vet Parasitol 1999;76:269-74.
22. Praet N, Rodriguez-Hidalgo R, Speybroeck N, et al. Infection with versus Exposure to Taenia solium: what do serological test results tell us? Am J Trop Med Hyg 2010;83:413-5.
23. Dorny P, Phiri IK, Vercruysse J, et al. A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. Int J Parasitol 2004;34:569-76.
24. Carabin H, Millogo A, Praet N, et al. Seroprevalence to the antigens of Taenia solium cysticercosis among residents of three villages in Burkina Faso: a cross-sectional study. PLoS Negl Trop Dis 2009;3:e555.
25. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72.
26. Kouassi B, Koffi JK, Diarra JA. Prevalence of epilepsy in rural Ivory Coast: a pilot study. Pub Méd Afr 1998;89:25-30.
27. Njamnshi AK, Sini V, Djientcheu V. Risk factors associated with epilepsy in a rural area in Cameroon: a preliminary study. Afr J Neurol Sci 2007;26:18-26. http://www.ajns.paans.org/article.php3?id_article=228.
28. Rwiza HT, Kilonzo GP, Matuja WBP. Prevalence, incidence of epilepsy in Ulanga, a rural Tanzanian district: a community-based study. Epilepsia 1992;33:1051-6.
29. Debouverie M, Kabore J. Epidémiologie de l'épilepsie au Burkina Faso. In: Dumas M, Giordano C, Gentillini F, eds. Neurologie tropicale. Paris: John Libbey Eurotex, 1993: 57-61.
30. Schoenberg BS. Clinical neuroepidemiology in developing countries: neurology with few neurologists. Neuroepidemiology 1982;1:143-53.
31. Tekle-Haimanot R, et al. Clinical and encephalographic characteristics of epilepsy in rural Ethiopia: a community-based study. Epilepsy Res 1990;7:230-9.
32. Quet F, Guerchet M, Pion SDS, Ngoungou EB, Nicoletti A, Preux PM. Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 2010;51:830-7.
33. Schantz PM, Moore AC, Muñoz JL, et al. Neurocysticercosis in an orthodox Jewish community in New York City. N Engl J Med 1992;327:692-5.
34. Overbausch D, Oosterhuis JW, Kortbeek LM, Garcia-Albea E. Neurocysticercosis in Europe. In: Craig P, Pawlowski Z, eds. Cestode zoonoses: echinococcosis and cysticercosis - a global emergent problem. Amsterdam: IOS Press, 2002; 33-40.
35. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002;8:608-13.
36. Degiorgio C, Pietsch-Escueta S, Tsang V, et al. Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurol Scand 2005;111:84-8.
37. Secka A, Grimm F, Victor B et al. Epilepsy is not caused by cysticercosis in the Gambia. Trop Med Int Health 2010;15:476-9.
38. Arpino C, Gattinara GC, Piergili D, Curatolo P. Toxocara infection and epilepsy in children: a case-control study. Epilepsia 1990;31:33-6.
39. Garcia HH, Modi M. Helminthic parasites and seizures. Epilepsia 2008;49:25-32.